For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
Law is flawed for doctors and patients
+Opinion
In print
Etcetera
Law is flawed for doctors and patients
Tuesday 13 October 2020, 04:01 PM

NO
Thaya Ashman doesn’t want to be labelled simply as being against the End of Life Choice Act. The act has shortcomings that have not been addressed
We are being asked to make a choice as to whether we are for or against the binding end of life choice legislation.
Ethics and opinions aside, we h
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.